What they did: They took 80 rats (Wistar strain), completely transected their Achilles tendon (the strongest tendon in the body) and divided them into 3 groups: Control , saline BPC-157 by injection , 10 g/kg into the abdominal cavity BPC-157 in drinking water , 10 g/kg orally After 14 days they tested the tensile strength of the healed tendon and performed histology (microscopic examination of the tissue)
As healthcare systems focus on preventive measures and effective treatment options for these chronic conditions, the demand for GLP-1 receptor agonists is expected to grow, driving market expansion
Months after recovering from the initial SARS-CoV-2 infection, or following the onset of a complex neuroimmune condition like myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), many people find themselves fighting debilitating symptoms that seem to have no clear origin
Total protein: ~20g
Recent Trends in GLP-1 Use and Spending in Medicare Ahead of the Trump administrations planned expansion of Medicare coverage for GLP-1s to treat obesity through temporary models and the availability of Medicares negotiated price for certain GLP-1 products beginning in 2027, new data from the Centers for Medicare & Medicaid Services (CMS) shows that use and spending for these drugs under Medicare has grown substantially in recent years, reflecting their demonstrated effectiveness at treating type 2 diabetes and other conditions
Online counterfeits and "no-prescription" sellers are a known danger